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Rupani R.N., Pawelek J.M. Co-localization of (31,6-Branched Oligosaccharides and Coarse Melanin in 
Macrophage-Melanoma Fusion Hybrids and Human Melanoma Cells In Vitro. Department of 
Dermatology, Yale University School of Medicine, New Haven, CT. 
Fusion hybrids between nonrial macrophages and Cloudman S91 melanoma cells were shown in previous 
studies to have increased metastatic potential, along with high expression of (3 1,6-N- 
acetylglucosaminyltransferase V (GnT-V) and (31,6-branched oligosaccharides. Curiously, hybrids, but not 
parental melanoma cells, also produced ‘coarse melanin’— autophagic vesicles with multiple melanosomes. 
Since (31,6-branched oligosaccharides were known to be associated with metastasis, and coarse melanin 
had been described in invasive human melanomas, the purpose of this study was to look for potential 
relationships between the two. Using lectin/immunohistochemistry, we analyzed cell lines producing coarse 
melanin for (31,6-branched oligosaccharides; gpl00/pmel-17, a melanosomal structural component; and 
CD63 a late endosome/lysosome component highly associated with melanoma and certain other human 
cancers. Cell lines were hybrid 94-H48, a highly metasatatic, macrophage-melanoma artificial fusion 
hybrid; 6nL0 mouse melanoma cells, the weakly metastatic, parental fusion partner; and SKMel-23, a human 
melanoma cell line derived from a metastasis. Coarse melanin granules were prominent in both hybrids and 
SKmel-23 cells, and co-localized with stains for (31,6-branched oligosaccharides, gplOO/pmel 17, and 
CD63. Co-expression of (31,6-branched oligosaccharides and coarse melanin was recently shown to be a 
common and pervasive characteristic in archival specimens of human melanomas (most prominently in 
metastases), but this is the first report of this phenotype being expressed in vitro. Such expression in both 
human melanoma cells and experimental macrophage-melanoma fusion hybrids provides new biological 
systems for more detailed analyses of its genesis and regulation at the molecular genetic level. 
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INTRODUCTION 
A detailed discussion of melanoma, which is principally (but not exclusively) a 
cancer of epidermal melanocytes, first requires a succinct review of the skin itself. As the 
body’s largest organ, the skin serves a variety of functions including, fundamentally, the 
maintenance of a constant internal environment. In order to accomplish this, the skin 
functions in photoprotection, thermoregulation, cutaneous circulation, barrier formation, 
and immunologic protection (1). 
The outer layers of the skin comprise the epidermis, which is subdivided from top 
to bottom into the stratum corneum, stratum granulosum, stratum spinulosum, and 
stratum basale. 
(c) 2003 Elsevier - Bologma, Jonzzo and Raptni: Dermatology - www.dermtcxt.com 
Figure 1. Human epidennis/dermis. The five layers of the epidermis are visible from top to bottom. 
The major cellular components of the epidermis are keratinocytes, melanocytes, and 
Langerhans cells; melanocytes are embryologically-derived from the neural crest, and 
with their capacity to elaborate the radiation-absorbing pigment melanin, play a primary 
role in protecting the skin and body from ultraviolet radiation damage. Melanin is 
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packaged into melanosomes, which are subsequently transferred through melanocyte 
dendritic processes into neighboring keratinocytes, where they then reside in a 
perinuclear location (1). 
© 2003 Elsevier - Bolognia, Jorizzo and Rapini: Dermatology - www.dermtext.com 
Figure 2. Nonrial human melanocyte stained for tyrosinase. 
Finally, beneath the epidermis lies the dermis, a mucopolysaccharide gel bound by a 
collagen and elastin-containing fibrous matrix, which is vascularized to provide both 
nutritional and structural support to the skin (1). 
Given this brief structural and functional outline of normal epidermis and dermis, 
we turn to the example of disordered epidermal cellular function which is the particular 
focus of this study: melanoma, a malignant tumor arising from melanocytes. The 
incidence of melanoma and its associated mortality rates are increasing, particularly 
amongst younger individuals (1). Diagnosis includes attention to early sunburns and 
intense intermittent exposure to sun in individuals with types I or II skin (although 
melanoma in darker-skinned individuals can occur on non-sun-exposed areas such as 
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acral sites). Clinical features are characterized by the ABCD mnemonic for evaluation 
of any suspicious lesions (asymmetry, border, color variation, diameter), and studies 
have shown that melanomas present more typically on the trunk in males and on the 
lower extremities in females (1). Histology reveals cellular atypia, mitoses, and invasion 
of the epidermis (2), and tumor thickness remains the most important prognostic indicator 
in primary melanoma (i.e., Breslow thickness scale). Melanomas can be extremely 
aggressive if not discovered early enough; metastases can occur in various organs 
including the lungs, liver, and central nervous system, with homing behavior often 
following the neural crest pattern of embryologic origin, resulting also in cutaneous 
metastases. 
An important question is how or why, in fact, such metastatic spread occurs. Key 
components of metastasis include an imbalance in regulation of adhesion, motility, and 
proteolysis, but the origins of cells with a metastatic phenotype are as yet unknown (3). 
The metastatic transformation of a primary melanoma is likely a multimodal process: 
“There are of course numerous examples correlating cancer with genetic changes, and in 
primary tumors many gene mutations have been identified that lead to cellular 
immortalization. But fewer gene mutations have been identified that correlate with 
metastasis, and indeed the strongest correlation for genetic changes in metastasis is 
aneuploidy as opposed to direct gene mutation.” (4). In thinking of metastasis as an 
evolutionary process (i.e., a process whereby acquired genetic variability allows the 
selection of more aggressive cell sublines [5]), there arises the question of whether there 
is a role for hybridization in the generation of cellular aneuploidy—meaning, a genetic 
fusion event between a phagocyte and a melanoma cell (e.g., during the abortive 
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digestion of apoptotic tumor cells by phagocytes), thereby yielding a hybrid which 
demonstrates features of both parental lines including myeloid-type mobility and the 
deregulated growth of cancer cells. 
Figure 3. Macrophage x melanoma fusion hybrids (6). 
Thus, as the genes for mitochondria and chloroplasts were acquired via endosymbiosis 
between pro-eukaryotes and prokaryotic cells, such is the logic for the theory of hybrid 
formation between myeloid and primary tumor cells (4). 
The idea of hybridization as a source of aneuploidy in cancer dates back to the 
research of Theodor and Marcella Boveri in the late 1800s: Their work with sea urchin 
eggs, which were experimentally fertilized with two different sets of spermatozoa, 
resulted in abnormal mitoses and led to the speculation that chromosomal imbalance 
might also play a role in the deregulated growth of cancer cells (7). These findings 
prompted Aichel in the early 20th century to extend the notion of chromosomal excess to 
human cancers, specifically the idea that hybridization between leukocytes and cancer 
cells might lead to genetic pooling/chromosomal imbalance, and therefore abnormal 
mitoses (8-9). Finally, Mekler in 1971 formulated the concept that hybridization between 
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immortalized tumor cells and leukocytes might confer properties of motility (i.e., that 
which is necessary for metastasis) to cells of the primary tumor (10). Indeed, today it is 
well-documented in animal models that tumor hybrids occur spontaneously (11-13). 
Also, leukocyte x lymphoma and leukocyte x melanoma fusion hybrids demonstrate 
increased moility in vitro and metastatic potential in vivo (11-13). 
With specific regard to melanoma there have been many studies, including those 
by Munzarova et al, Pernick et al, and others (14-16), which noted not only the 
expression of macrophage-like traits by metastatic melanoma (such as invasive behavior, 
chemotactic migration with reversible adhesive contacts, accumulation in draining 
lymphoid tissue, extravasation and release into circulation [17]) but also the presence of 
known histiocytic markers such as Mac-1 and CD68 on metastatic melanoma cells, as 
evidenced by immunoreactivity (16, 18-19). Both artificial and naturally-occuring tumor 
x host hybrids in mouse models were previously studied and noted to have enhanced 
metastatic capabilities (20-31). 
Thus, it was in the context of this historical and experimental background that the 
theory of macrophage-melanoma cell hybridization was tested in this thesis. This study in 
particular centered around a known phenomenon in highly metastatic cell lines and solid 
tumors (including breast, colon and others [32]), which is an increased level of (31,6- 
branched N-glycosylation of integral membrane proteins. Such proteins include 
lysosome-associated membrane proteins (LAMPs) 1&2, which are over-expressed in 
malignant cells and likely serve to stabilize lysosomes for transport to the cell membrane, 
with subsequent extracellular release of lysosomal enzymes for degradation of 
surrounding tissue (6); (3-integrins, essential for cell adhesion to fibronectin; cadherins, 
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involved in Calcium-mediated cell-cell adhesion properties; matriptase, which (among 
other functions) activates the HGF/cmet motility pathways; and other proteins which 
are as yet uncharacterized. This form of glycosylation is catalyzed by the myeloid-type 
enzyme GnT-V, or (31,6-N-acetyl-glucosaminyltransferase-V. 
(31,6-branched glycosylation is employed in motility by both myeloid cells and 
cancer cells, conferring changes in substrate adhesion, loss of contact inhibition, and 
activation of motility-promoting integrins such as cx5(31 (6, 32-34). (31,6-branching is 
catalyzed by the trans-Golgi enzyme GnT-V (E.C.2.4.1.155) and initiates the addition of 
polylactosamine antennae to the mannose-rich core of N-glycans. 
Polvlactosamine chain GnT-V 
SAa2-3(Gal pl-4GlcNAc pl-3)n Gal pl-4GlcNApi-6 
SAcx2-3 Gal pi-4 GlcNAc pi-2 Mancxl-6 
Man pi-4 GlcNAc pi-4 GlcNAc 
SAa2-3 Gal pi-4 GlcNAc pi-2 Mapa 1-3 
SAa2-3 Gal pi-4 GlcNAc pi-4' 
Figure 4. N-acetylglucosaminyltransferase V (GnT-V) involved in P 1,6 branch formation and 
polylactosamine chain synthesis. Man - mannose, GlcNAc - N-acetylglucosamine, Gal - galactose, SA - 
sialic acid. 
As principal carriers of N-acetylpolylactosamine antennae, LAMPs-1 and -2 are the most 
densely N-glycosylated of cellular proteins; synthesis of these antennae is catalyzed by 
GnT-V in the trans-golgi apparatus, where (31,6 branches are formed on the trimannosyl 
terminus of Asn-linked oligosaccharides (35). This in turn facilitates the enzymatic 
addition of (31,6-GlcNAc-linked poly-N-acetyllactoseaminyl chains by UDPGlcNAc-N- 
acetyllactoseaminide (31,3-N-acetylglucosaminyl transferase (36). These 
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polylactosamines are carriers of Lewis1 and Lewis" antigens, used in selectin binding 
during intravasation and systemic migration, and associated with poor patient prognosis 
in human cancers (6, 32-34). Thus, in summary, the enzyme GnT-V regulates the 
polylactoseamine contents of N-linked oligosaccharides with its activity serving as an 
indication of [31,6-branching, and elevated GnT-V activity is characteristic of both 
myeloid cells and metastatic melanoma cells (35). 
In our lab’s previous studies of artificial fusion hybrids between normal 
macrophages and a weakly metastatic mouse melanoma cell line, approximately half of 
the hybrids demonstrated GnT-V expression and (31,6-branched glycosylation similar to 
that of the parental macrophages and three to four times that of the parental melanoma 
cells (35). This correlated with dramatic phenotypic changes that, at least in some cases, 
appeared to be due to altered N-glycosylation. For example, hybrid clones with elevated 
GnT-V showed enhanced chemotactic motility in vitro that was suppressed by N- 
glycosylation inhibitors such as swainsonine and castanospermine (17, 37). Hybrids with 
elevated [31,6-branched glycosylation also tended to be highly pigmented, as opposed to 
the nonpigmented parental melanoma cells. Enhanced pigmentation correlated with 
elevated N-linked glycosylation of melanosomal proteins tyrosinase (the rate-limiting 
enzyme in melanogenesis), TYRP-1 (tyrosinase-related protein 1), dopachrome 
tautomerase (TYRP-2), and LAMP-1, and was again suppressed by N-glycosylation 
inhibitors and glycosidases (38-39). Hybrids also acquired enhanced responsiveness to 
inducers of intracellular cyclic AMP— MSH (melanocyte-stimulating hormone, 
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melanocortin-I) and IBMX (isobutylmethylxanthine, cholera toxin)— with increased 
pigmentation, motility, and dendricity (17, 35, 37-39). 
A curious finding was that melanosomes in artificial melanoma-macrophage 
(both mouse and human) hybrids were often packaged together in heterogeneous ‘coarse 
melanin’ vesicles, rather than existing free in the cytoplasm as in normal melanocytes and 
parental melanoma cells. Coarse melanin was first described in relation to animal-type 
melanoma in 1832, and then in humans in 1925 (40). It was described by Clark et al as a 
major melanosomal abnormality primarily associated with cells in vertical growth phase 
melanomas, consisting of numerous granular organelles, 250-500nm in width with 
melanin deposited in a coarsely granular fashion, commonly seen in superficial spreading 
melanoma, in nodular melanoma, and in metastatic melanoma (41). 
Similarly, recent studies from our laboratory of human archival melanoma and 21 
other cancers universally revealed for the first time the production of ‘coarse’ 
autophagosomal vesicles, apparently a shared phenotype associated with elevated GnT-V 
activity (32). This phenotype was an independent predictor of metastasis and poor 
survival in melanoma, breast, and colon carcinomas. In melanomas, the autophagosomes 
were often laden with coarse melanin, accounting for the well-known hypermelanotic 
regions of primary tumors used in clinical diagnosis. The association between this 
phenotype and elevated GnT-V activity was established via immunoperoxidase staining 
for a particular marker of (31,6-branched structures known as LPHA, as well as by 
staining with antibodies against HMB45 and CD63. 
LPHA, or leukocyte-phyto-hemagglutinin, is a lectin derived from the plant 
phaseolus vulgaris which binds to and thus identifies (31,6-branched structures. HMB45 
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is an antibody to human melanosomal membrane protein gplOO (pmell7 is the mouse 
homolog, used herein). CD63 is a glycoprotein that was first discovered as a 
melanoma-associated antigen (42-44) but has since been found in a number of other 
neoplasms and normal cells (32, 45-46). CD63 belongs to the transmembrane 4 
superfamily, or tetraspanins, a large family of membrane proteins associated with cell 
proliferation, cell migration, and tumor cell invasion (47-49), in part through affecting 
integrin signaling and differential adhesion (50-54). CD63 is usually found in association 
with LAMPs 1 and 2, both major substrates for GNT-V, and it would thus be expected to 
co-localize to structures containing (31,6-branched N-glycans. 
There have been previous studies documenting vesicle formation in various 
other models, with a postulated link to GnT-V activity. Fukuda et al, for example, 
discussed a case of a pigmented renal cell carcinoma which demonstrated collections of 
“abnormal lysosomal granules” (55). It was also of considerable interest to us that Hariri 
et al (56) reported formation of autophagy-dependent “multilamellar vesicles” following 
transfection of GnT-V into non-neoplastic mink alveolar type II lung cells. The vesicles 





Thus, in the setting of historical knowledge of GnT-V activity and aberrant 
glycosylation in neoplastic cells, and previous findings by our lab of increased GnT-V 
levels and a coarse vesicular phenotype in human melanomas and other solid tumors, the 
purpose of this study was to confirm said findings in an in vitro model via histochemical 
analyses of known GnT-V substrates/markers in an artificial mouse macrophage- 
melanoma hybrid cell line and a human melanoma cell line. It was hypothesized that 
coarse melanin vesicles in macrophage-melanoma fusion hybrids might also be related to 
GnT-V expression. As such, I show below that melanized autophagosomal vesicles in 
experimental macrophage-melanoma fusion hybrids were indeed rich in [31,6-branched 
N-glycans, and that such structures were also a feature of human melanoma cell lines in 
vitro. The biological significance of this phenotype is not understood; however, the 
strong relationship to metastasis makes it of obvious interest. The cultured cell lines 
provide new biological systems for analysis of GnT-V regulation and TV-linked 
glycosylation at the molecular genetic level. 
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MATERIALS AND METHODS 
Two cell lines utilized in this study (S91-6wo and hybrid 94-H48) were 
previously generated in our lab by Dr. John Pawelek and Michael Rachkovsky. Cells 
were prepared for electron microscopy by Dr. John Pawelek. Experiments and analysis 
conducted by myself included the following: Cell culture and maintenance, fixation 
(protocol kindly provided by Dr. Ruth Halaban, Ph.D., Yale University Department of 
Dermatology), bleaching (protocol kindly provided by Vincent Klump, Yale University 
Department of Dermatopathology) and immunoperoxidase staining; additionally, under 
the guidance of Dr. John Pawelek, I photographed cells under both the electron and light 
microscopes; I prepared cells for FACS analysis under the supervision of Dr. Ashok 
Chakraborty, as well as carried out the experiments and ensuing computer data analyses; 
transfection experiments (see Discussion) were performed by Dr. Ashok Chakraborty and 
cells were analyzed by myself under the light microscope; finally, I performed all cell 
counts and statistical analyses. 
Cell lines: As stated above, two of the cell lines here studied, namely S91 -6nc' and hybrid 
94-H48, were previously generated in our lab by other researchers. Methods are here 
paraphrased (17): Melanoma cells and macrophages were maintained in HAM’s F10 or 
Dulbeco’s MEM media with the addition of 10% fetal bovine serum (mouse cells) or 
15% human serum (human macrophages). Cells were maintained in a gassed and 
humidified incubator (5% C02 in air, 37°C). The cell line used as a control partner for 
fusion with macrophages was identified as Cloudman-S91 (PS-l-HGPRT-1), and 
generated as follows: The S91 tumor originated as a malignant melanoma in the tail base 

12 
of a DBA female mouse, and after subsequent transplantation to another mouse tail, 
showed a striking amount of highly-pigmented pulmonary metastases (57). Via 
subsequent transplantations into different DBA mice, this tumor was maintained through 
successive generations. Clone M3 was adapted to culture from a transplanted S91 tumor 
and deposited with the American Type Culture Collection (58), then manipulated in our 
laboratory. PS1-HGPRT-1 was again isolated by resistance to azaguanine and 
thioguanine, then further selected for resistance to neomycin (which typically destroys 
macrophages). Similarly, spontaneous hybrids within this clone were isolated by 
resistance to hypoxanthine, aminopterin, thymidine (HAT, which typically destroys S91 
cells) and/or neomycin, as hybrids are resistant to both neomycin and HAT. 
Peritoneal macrophages were obtained from DBA/2J mice four days after 
injection with 3ml of thioglycollate broth (Difco) and immediately prepared for fusion 
experiments. Human blood monocytes were donated by a member of the lab, isolated by 
standard Ficoll density centrifugation techniques, and kept in monolayer culture for 72 
hours before use in fusion experiments (17). 
Creation of the hybrid cell line was accomplished previously by polyethylene 
glycol fusion (PEG), and is here paraphrased (17): PS1-HGPRT-1 neomycin -resistant 
Cloudman-S91 cells were mixed with macrophages (separately mouse and human) at 
respective ratios (tumor/macrophage) between 1:4 to 1:10. Polyethylene glycol (PEG 
1450, Sigma Chemicals) was dissolved by warming and mixed in a 50:50 volume ratio 
with Ham’s F10 serum-free nutrient medium. Mixed PEG/F10 (0.8ml) was added to 
centrifuged cell pellets over a period of 1 minute at 37° C, with gentle mixing. The 
suspension was maintained at 37° C and continuously mixed for an additional minute; 
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this procedure was followed by the addition of 1ml of Ham’s F10 over another minute, 
and then 20ml of Ham’s F10 over 5 minutes. The mixture was finally centrifuged, 
supernatant withdrawn, and cells seeded into 25 cm2 Corning tissue culture flasks 
(concentration 1.5 x 105 cells/flask). These flasks were maintained in a gassed and 
humidified incubator at 37° C for 48 hours, after which time the initial medium was 
replaced with medium containing HAT (concentrations^ hypoxanthine 1 x 1 O'4, 
aminopterin 4 x 10'7, thymidine 1.6 x 10'5) +/- neomycin, depending on the experiment. 
Hybrid cells, then, were identified as those resistant to both HAT and neomycin (17). 
Only mouse/mouse hybrid cells were ultimately used in this study. 
Pigmented human metastatic melanoma cell lines SKmel-23 (clone C22), 
SKmel-30, and SKmel-188 (59) were kindly provided by Dr. Alan Houghton, Sloane- 
Kettering Memorial Institute for Cancer Research. 
Cell culture: Cells (5 x 104), in 0.2ml DMEM/10% fetal bovine serum with penicillin 
and streptomycin were plated onto Snowcoat sterile glass slides. Medium was changed 
the following day, and half of the cultures were supplemented with MSH (2xl0‘7M) 
and 3-methyl isobutylxanthine (10‘4M). Cultures were incubated in a gassed 
(5%C02/95% air), humidified incubator at 37"C, reaching 60-75% confluence (by visual 
approximation) by 3 days when they were processed for lectin/immunohistochemistry. 
For fixation, cultures were gently rinsed in phosphate-buffered saline, immersed in 
methanol (100%, 1 min), and then air-dried. 
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Coarse melanin co-localization. Coarse melanin was identified and photographed in 
unstained cells using an Olympus AH2 light microscope/camera adapted with Spot'" 
software, and microscope coordinates of the region were recorded. The sections were 
bleached (below), then lectin-, or immunostained via standard horseradish peroxidase 
techniques, counter-stained with hematoxylin, and the same regions were again located 
and rephotographed. 
Bleaching: To decolorize melanin, slides were immersed in tap water for 24 hours to 
dissolve the water-based mounting medium (Clearmount, Zymed Laboratories Inc.) and 
passively remove cover slips. The cells were then bleached by immersion in KMn04 
(0.25%, 4 min.); rinsed in distilled water; immersed in oxalic acid solution (1%, 1 min.); 
washed in gently-running tap water (2 min); and rinsed twice in phosphate-buffered 
saline to restore pH. The slides were monitored under the light microscope to ensure that 
bleaching was complete. 
Lectin- and Immunohistochemistry: Slides were processed and stained by the Dako'M 
immunoperoxidase technique: The slides were incubated in peroxidase block for 5 
minutes and rinsed in phosphate-buffered saline to restore pH. Biotinylated primary 
antibodies (described below) were applied, and slides were incubated for a period of 15 
minutes before rinsing with PBS. This was followed by a 15 minute incubation in 
streptavidin-peroxidase and another PBS rinse, and the procedure was completed with a 
5-minute incubation in prepared DAB+substrate-chromagen solution and tap water rinse. 
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After immunoperoxidase staining, each slide was counterstained using filtered Gil III 
Hematoxylin (10 second rinse), a 1 second immersion in Ammonium Hydroxide (1%), 
and a running tap water rinse. The slides were then dehydrated in 100% ethanol and 
mounted with coverslips using a Xylene-based mounting medium (Cytoseal 60 low 
viscosity, Richard Allan Scientific). 
Antibodies and lectins were as follows: HMB45 (anti-human melanosomal 
component gplOO; prediluted by company, 1:50 dilution) was from Dako, Inc., 
Carpinteria, CA. Anti-pmel-17 (mouse homologue of human gplOO, 1:50 dilution) was 
kindly provided by Dr. Vincent Hearing, US National Cancer Institute. Anti-CD63 
(MAbME491; lysosome/late endosome component; 1:20 dilution) was a kind gift of Dr. 
M. Herlyn, Wistar Institute, Phila. PA. Biotinylated. LPHA (1:50 dilution), for detection 
of (H ,6-branched N-glycans, was from Vector Laboratories, Burlingame, CA. 
Electron Microscopy. Fixation/preparation was conducted by other researchers in our 
lab. Cells were fixed in half-strength Karnovsky's fixative for 6 hrs at 4°C; washed in 
cacodylate buffer overnight; post-fixed with 1% Os04 and 1.5% potassium ferrocyanide 
in cacodylate buffer for 2 hrs; and embedded in Spurr's resin. Ultrathin sections were 
stained with uranyl acetate and lead citrate, and photographed by this author through a 
Zeiss 109 electron microscope. 
FACS Analysis. Analysis was carried out for LPHA only, in 6n“ and hybrid 48 cells (no 
human melanoma cell analysis). LPHA binding was facilitated by incubating cells with 

16 
FITC-conjugated LPHA (lOpg/ml; Vector, Burlingame, CA) in phosphate-buffered 
saline with 0.1% bovine serum albumin and 0.05% sodium azide (to prevent fungal 
contamination). After 3-4 washings with PBS, cells were fixed with 1% 
paraformaldehyde. Flow cytometry was carried out using a FACS Vantage flow 
cytometer (Becton Dickinson). Predominantly cell surface expression of LPFIA target 
ligands was measured, as the antibody and lectin incubations were performed with intact 




Quantitation of pmel-17/gpl00 and (51,6-branched oligosaccharides. The three cell 
lines, with and without MSH/IBMX treatment, were scored as to the percentage of cells 
in the population staining for LPHA and anti-pmel-17/gpl00 (Figure 5). 
100 
6neo 94-H48 SK.mel-23 6neo 94-H48 SKmel-23 
Figure 5. Relative expression of pmel-17/gpl00 and (31,6-branched oligosaccharides in cell 
lines 6neo, hybrid 94-H48, and SKmel-23, cultured in the absence and presence of MSH/ 
IBMX (Methods). Following staining, the three lines were scored under a light microscope 
as to the percentage of cells positive for LPFIA or anti-pmel-17 (mouse)/gp 100 (human). 
Results represent mean + /- S.D. for three separate counts of 100-200 cells each. 
A. LPHA, control; B. LPHA, MSH/IBMX; C. anti-pmel-17/gp 100, control; D. anti- 
pmel-17/ gp 100, MSH/IBMX. 
In the absence of MSH/IBMX, hybrid 94-H48 and SKmel-23 cells each showed a higher 
percentage of LPHA- and HMB45-positive cells compared to parental 6"° melanoma 
cells, and for hybrid cells this was increased further following exposure to MSH/IBMX. 
(P values were computed by Student’s t-Test using the Statview™ program, and for these 
differences were all less than P=.0060.) In the absence of MSH/IBMX, SKmel-23 cells 
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showed even higher numbers of positive cells than did hybrid 94-H48, with >90% of 
the population positive for LPHA and >80% positive for HMB45. Exposure of SKmel- 
23 cells to MSH/IBMX did not further increase this already high percentage of positive 
cells, although it did promote an increase in dendrites (not shown). 
On a ‘per cell’ basis, the staining intensity in hybrid 94-H48 and SKmel-23 cells 
was estimated (by visual approximation) as about 4-5 times greater than that seen in 
parental 6ncocells, consistent with flow cytometry data conducted previously by other 












Figure 6. Comparison of parental 6IU0 melanoma cells and hybrid 94-H48 following staining with LPHA. 
Left: 6n'"°, arrows denote LPHA staining. Right: 94-H48, arrows denote LPHA staining. Cells were treated 
with MSH/IBMX. 
Thus, from both ‘population percentage’ data and ‘per cell’ estimates, hybrid 94-H48 and 
human melanoma SKmel-23 each showed significantly higher expression of pmel- 
17/gpl00 and (31,6-branched oligosaccharides compared to parental 6nc" melanoma cells. 
Coarse melanin in hybrid 94-H48. H&E staining revealed little to no melanin in the 

19 
parental 6"cu cells, but most of the hybrid cells were heavily pigmented with coarse, dark 
melanin throughout the cytoplasm (Figure 7). 
Figure 7. Comparison of parental 6neo melanoma cells and hybrid 94-H48 following staining 
with H&E. Left: 6nco, H&E stain; lighter perinuclear area denotes Golgi region. Right: hybrid 
94-H48, H&E stain; dark, coarse melanin visualized in perinuclear region. Cells were treated 
with MSH/IBMX. 
Electron micrographs revealed that although some melanosomes existed freely in the 
cytoplasm, the coarse granular appearance of melanin in hybrid 94-H48 was due to 
melanosome-filled autophagasomes in various stages of maturation (60) (Figure 8). 
Figure 8. Electron micrograph of macrophage-melanoma hybrid 94-H48 in culture with coarse 
melanin (melanosome-containing autophagosomes (arrows) in various stages of 
maturation), (n, nucleus; magnification, 30,000x). Cells were treated with MSH/IBMX. 
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LPHA staining of 6nco cells revealed an acentric, perinuclear pattern, highlighting the 
Golgi region (Figure 7 above, left). LPHA staining in hybrid 94-H48 was far more 
extensive, resembling the melanization pattern and encompassing large portions of the 
cytoplasm to obscure the nucleus (Figure 7 above, right). 
Co-localization studies in hybrid 94-H48 cells, revealed that both LPHA and anti- 
pmel-17 co-localized to coarse melanin, demonstrating that these structures contained 
both [31,6-branched oligosaccharides and melanosomal matrix proteins (Figures 9 & 10). 
Figures 9 and 10 (below). Mouse macrophage-melanoma hybrid 94-H48. Co-localization of 
coarse melanin with |31,6-branched oligosaccharides and pmel-17. Left: unstained sections; 
right: the same sections bleached and stained with LPHA (upper) or anti-pmel-17 (lower). 













CD63 was not investigated in depth in the mouse cell lines, because the antibodies 
available were antihuman and did not cross-react well with mouse melanoma cells. 
Coarse melanin in human melanoma cell line SKmel-23. SKmel-23 human metastatic 
melanoma cells exhibited prominent dendrites, often in a bipolar morphology. Melanin 
granules were seen throughout the cell body and dendrites, and appeared to protrude from 





Figure 11. Fluman SKmel-23 melanoma cell with coarse melanin. 
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Co-localization studies revealed that the melanin granules stained with LPHA (Figure 
12), anti-HMB45 (Figure 13), and anti-CD63 (Figure 13). 
Figures 12-14 (below). Human SK.mel-23 melanoma cells. Co-localization of coarse melanin with 
(31,6-branched oligosaccharides, gplOO, and CD63. Left: unstained sections; right: the same 
sections bleached and stained with LPHA (upper), anti-HMB45 (middle), or anti-CD63 (lower). 










Electron microscopy demonstrated that although some melanosomes were free in the 
cytoplasm, most were packaged in autophagosomes and multilamellar bodies (Figure 15). 
Figure 15: Electron micrographs of human SKmel-23 cells. Each panel is an example of 
coarse melanin from a separate cell. Cells were treated with MSH/IBMX. 
LPHA-positive coarse vesicles were also observed in pigmented human melanoma cell 
lines SKmel-30 and SKmel-188 (not shown). 
FACS Analysis. Analysis of LPHA staining was carried out on 3 separate occasions for 
both the 6nc0 and hybrid cell lines, but data was inconsistent/inconclusive overall and 
therefore not here included. Possible explanations include errors in FACS preparation 




In the present studies, a newly-described cancer phenotype in humans, i.e. co¬ 
expression of coarse vesicles and (31,6-branched oligosaccharides (32), has been 
demonstrated in vitro. I have shown here that the phenotype was expressed in cultured 
human melanoma cells and could also be generated through fusion hybridization between 
normal macrophages and mouse melanoma cells. In macrophage fusion hybrids, the 
phenotype was enhanced by exposure to MSH in combination with IBMX, a potent 
stimulus for cyclic AMP production. SKmel-23 cells strongly expressed the phenotype 
whether or not they were treated with MSH/IBMX. 
GnT-V is normally elevated in macrophages and other phagocytes, where |31,6- 
branched polylactosamines with terminal Lewis* and Lewis* antigens are employed for 
selectin binding during intravasation and systemic migration (61-64). In the macrophage 
fusion hybrids described here, it is tempting to speculate that GnT-V was expressed as a 
transcriptionally dominant, developmentally-imprinted myeloid trait. In any case, since 
an LPHA-positive, vesicular phenotype is a characteristic of normal migratory cells, this 
might provide clues as to the relation between this phenotype and migration of malignant 
cells. 
It is also notable that human melanoma-associated melanophages are laden with 
LPHA-decorated, melanin-containing vesicles, thought to be phagolysosomes from 
phagocytosed melanoma cells (32). In mammalian cells, the process of macroautophagy 
is a known mechanism for degradation of intracellular macromolecules and organelles, 
thus playing a prominent role in controlling cell growth and protein metabolism (32). 
Indeed, by electron microscopy of cultured human Skmel 23 melanoma cells and 
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previous ultrastructural studies of human melanoma, results indicated that coarse melanin 
in melanoma is autophagosomal (4, 35; 65-69). Interestingly, GnT-V expression has also 
been shown to induce multilamellar bodies in mink type II alveolar lung cells through 
autophagy pathways, raising the possibility that the coarse vesicles observed herein might 
have been generated through the same GnT-V-mediated mechanisms (56). 
Coarse melanin also contained melanosomal structural protein gpl00/pmel-17, 
and in human melanoma SKmel-23, CD63. CD63 is a lysosome/late endosome protein 
(70-71), and is associated with the membranes of large vesicles such as macrophage 
phagolysosomes, secretory granules, multivesicular bodies, and multilamellar bodies 
ranging in size from 0.1 to 2.4 microns (56; 72-74). In archival human melanomas, CD63 
was always found associated with coarse vesicles, with or without melanin (32). As 
previously described (see Introduction), the association of CD63 with LAMPs 1 and 2 
creates expections that this protein should co-localize to structures containing (31,6- 
branched N-glycans, as shown herein (56). 
These studies were an outgrowth of previous work from our lab on macrophage- 
tumor cell fusion hybridization and metastasis (3-4, 17, 35, 37-39, 56). Fusion of 
leukocytes with “somatic cells” was first proposed as a mechanism of malignant 
transformation to explain the increased number of chromosomes in cancer cells (7-9). 
Spontaneous fusion of tumor cells has since been well-documented in animal tumor 
models (3-4). In non-cancer systems, fusion involving bone marrow-derived stem cells 
was an underlying basis of liver regeneration in mouse models, and has been proposed as 
an alternative to the concept of stem cell transdifferentiation as a mechanism for 

26 
development and maintenance of a variety of differentiated cell types (75-77). Indeed, 
there is considerable literature on cell-cell fusion within a variety of biological systems. 
Our previous findings that artificial macrophage-melanoma fusion hybrids 
demonstrated elevated expression of (31,6-branched N-glycans as well as production of 
coarse vesicles led to the co-localization studies on cultured cells described herein, as 
well as to a recent survey of archival human specimens where this phenotype was 
observed in 22 different cancers including melanoma (32). In this same study, the coarse 
vesicular phenotype was particularly expressed in metastases compared with primary 
melanomas (P< 0.008), suggesting that LPHA positivity (and therefore GnT-V activity) 
in primary tumors may be a sign of increased metastatic competence (32). 
Although there are numerous regulatory systems involved in metastasis, there is a 
significant body of evidence that elevated GnT-V activity is an important factor. It has 
been shown that rodent cells transformed with Rous sarcoma/polyoma viruses or 
transfected with H-ras oncogenes have displayed increased (31,6-GlcNAc branched 
complex oligosaccharides and higher polylactosamine levels (78), and in another study, 
the loss of GnT-V activity in a glycosylation mutant of a highly metastatic cell line was 
associated with a loss of metastatic potential in mice (79). Very recent data also shows 
that the her-2/neu oncogene actually stimulates the transcription of GnT-V in human 
breast carcinoma cells via the ras-raf-Ets signaling pathway (80). Thus, it is reasonable to 
conclude that increased GnT-V activity correlates with high metastatic potential in solid 




Yet, despite the known association between GnT-V activity and metastatic 
potential, the LPHA-positive vesicular phenotype has also been inducible or observed in 
non-malignant cells such as the mink type II lung cells previously described as well as 
leiomyomas and some pigmented cutaneous nevi (81). The question thus arises as to 
how one might reconcile these data; a possible explanation might be that expression of 
the LPHA-positive phenotype in itself is insufficient to induce a metastatic 
transformation, and the genetic context of this expression might play a significant role in 
cellular behavior. In other words, GnT-V activity in fully-deregulated neoplastic (but not 
merely hyperplastic) cells could affect tumor progression (32). 
Recent experiments in our lab involving the transfection of GnT-V (versus a 
“naked” plasmid control) into 6nco cells revealed provocative results: In both the plasmid 
control as well as the GnT-V transfected cell lines, we saw an increase in pigmentation as 
well as the presence of coarse vesicular structures. This begged the question as to 
whether it was the addition of the exogenous GnT-V gene which up-regulated cellular 
glycosylation machinery, or whether it was simply the exposure to any foreign DNA (as 
in the naked plasmid) which induced cells to up-regulate native GnT-V activity. (Insofar 
as all cells contain the same genetic material, there must also be some baseline low level 
of GnT-V activity even in our control 6nco cells. The point enforced thus far in this thesis 
is simply that the level of activity is significantly higher in cells of myeloid lineage.) 
These experiments are in the preliminary stages, however, and clearly warrant further 
study. 
Another recent study of interest by Taniguchi et al (one of the pioneers of GnT-V 
research) is that addition of (31,6 GlcNAc-branching to Asn 772 in the serine protease 
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domain of matriptase played a pivotal role in its stability and resistance against trypsin 
(82). Matriptase plays important roles in cell migration, extracellular matrix degradation, 
and the activation of single chain urokinase-plasminogen activator and hepatocyte growth 
factor, all of which are involved in metastasis (83). Once activated by GnT-V induced 
glycosylation, matriptase cleaves pro-HGF into HGF, which acts as a ligand to cell- 
surface cmet receptors (with an ensuing known pathway of increased motility and 
metastatic potential) (83). Hence, along with glycosylation of integrins and adhesion 
molecules, matriptase glycosylation may constitute yet another pathway for GnT-V 
-induced metastatic behavior in cancer cells. The diagram below summarizes some of the 








In summary, artificial mouse macrophage-melanoma fusion hybrids demonstrated 
a high level of GnT-V activity consistent with previous studies, as evidenced by 
increased immunoperoxidase staining for LPHA (both number of cells and per-cell 
intensity) compared to controls. The human melanoma cells even surpassed thefusion 
hybrids in terms of LPHA staining positivity. Additionally, the phenotypic finding of 
coarse melanin previously identified by our lab in a variety of solid tumors was here 
confirmed in an in vitro model. These autophagosomes were noted to contain numerous 

29 
melanosomes, and also stained positively for LPHA, HMB45/pmell7, as well as CD63 in 
the human cell line. Yet, the exact significance of the coarse melanin phenotype remains 
elusive, and at this point we can only make note of its expression and apparent link to 
GnT-V enzymatic activity. 
The precise molecular genetic mechanisms regulating GnT-V expression in the 
biological systems here described will require considerable further study, and must also 
be analyzed within the greater multimodal context of cancer biology. Overall, however, 
hybridization between melanoma cells and tumor-infiltrating macrophages appears to 
present a simple and unifying explanation for metastasis that is compatible with its 
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